FOS and hepatocellular carcinoma: Compared with control-treated cells, we observed that the expression of JunB and c-Fos was downregulated in 5-fluorouracil- and pirarubicin-treated HCC cells, and no obvious alteration in c-Jun mRNA levels was noticed (Figure.